Microvesicles/exosomes as potential novel biomarkers of metabolic diseases
Günter MüllerDepartment of Biology 1, Genetics, Ludwig-Maximilians University Munich, Biocenter, Munich, GermanyAbstract: Biomarkers are of tremendous importance for the prediction, diagnosis, and observation of the therapeutic success of common complex multifactorial metab...
Guardado en:
Autor principal: | Müller G |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/7f55c13c4cda4cb7b110d2d8103806c5 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Diet-induced metabolic hamster model of nonalcoholic fatty liver disease
por: Bhathena J, et al.
Publicado: (2011) -
The association between obesity, cardiometabolic disease biomarkers, and innate immunity-related inflammation in Canadian adults
por: Da Costa LA, et al.
Publicado: (2012) -
Metabolic abnormalities in pituitary adenoma patients: a novel therapeutic target and prognostic factor
por: Zheng X, et al.
Publicado: (2015) -
Disturbance of inorganic phosphate metabolism in diabetes mellitus: temporary therapeutic intervention trials
por: Jørn Ditzel, et al.
Publicado: (2009) -
Relationship between chronic kidney disease and metabolic syndrome: current perspectives
por: Nashar K, et al.
Publicado: (2014)